With Korean-born plastic surgeon Dr. Eunice Park at the helm, AIREM combines the latest Korean innovations with Western ...

There's a recent trend of states to include health care exemptions in DEI bans, but not all states have done so. The lack of ...

Cerebral cavernous malformation (CCM) patients treated with oral drug, REC-994, showed reduction in total cerebral and brainstem lesion volume.

Health tech company Inato developed an AI-powered patient pre-screening tool to make it easier and faster for research sites ...

I worked closely with NCI’s Investigational Drug Branch (IDB) from 1990-2016, including as a principal investigator of one of ...

The SAB-142 Phase 1 dose range was between 0.03mg/kg up to 2.5mg/kg, which demonstrated favorable safety profile based on the ...

Is compounded semaglutide effective for weight loss? Here’s the short version: Compounded semaglutide isn’t approved by the ...

Further, there can be no assurance at this time that successful results against coronavirus in our lab will lead to successful clinical trials or a successful pharmaceutical product. This press ...

This post was updated Jan. 31 at 12:28 a.m. Dr. Stephanie Smooke Praw, the interim clinical chief of UCLA Health’s Division ...

Using a pioneering artificial intelligence platform, researchers have assessed whether a cardiac AI tool recently trialed in South Australian hospitals actually has the potential to assist doctors and ...

Wong, Founder and CEO of HCW Biologics, commented, “The FDA’s clearance to initiate our first-in-human clinical trial for HCW9302 brings us one step closer to advancing a potentially transformative ...